Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.

Human antibodies and hybridomas Pub Date : 1994-01-01
P F Chen, R S Freedman, Y Chernajovsky, C D Platsoucas
{"title":"Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.","authors":"P F Chen,&nbsp;R S Freedman,&nbsp;Y Chernajovsky,&nbsp;C D Platsoucas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We have employed conventional polymerase chain reaction (PCR) and nonpalindromic adaptor PCR (NPA-PCR) for the amplification of the heavy- and light-chain transcripts of the cDNAs of two human monoclonal antibodies (MAb), designated AC6C3 (IgM, lambda) and CR4E8 (IgM, lambda), recognizing two different antigens expressed on the cell surface of human ovarian, cervix, breast, colon, melanoma and other carcinomas. With few exceptions these MAbs do not react with normal tissues. The AC6C3 MAb was developed by fusing regional lymph node lymphocytes from a patient with ovarian carcinoma with cells of the hybrid myeloma line SPAZ4, whereas the CR4E8 MAb was developed by fusing SPAZ4 cells with peripheral blood lymphocytes from a patient with cervical cancer, who was immunized intralymphatically with a viral oncolysate allogeneic tumor vaccine. The AC6C3 MAb immunoprecipitated from lysates of the ovarian tumor cell line SKOV3 a 32 kD polypeptide. The CR4E8 MAb reacted in Western blotting of lysates of the SW756 cervical carcinoma line with a 55 kD band. Cell surface immunofluorescence determinations using the fluorescence activated cell sorter revealed that both MAbs stain ovarian or cervix carcinoma tumor cell lines. We amplified the heavy chain transcripts of these two MAbs by conventional PCR, using mixed 5' end amplification primers, corresponding to the most conserved VH leader sequences and a C mu probe as a 3' end amplification primer. However, the mixed primer approach did not permit the amplification of the lambda-chain transcripts of these two human MAbs. This amplification was successfully carried out using the NPA-PCR that we have previously developed, specifically for the amplification of transcripts with unknown or variable 5' end, such as the T-cell receptors and the immunoglobulins. We have cloned and sequenced the amplified cDNAs. Sequence analysis showed that the V lambda segment of the AC6C3 MAb had 80.29% homology to the human germline Ig lambda-chain V lambda III.1, clone DPL2. The V lambda region of the CR4E8 MAb had 99.28% homology also to the human germline Ig lambda-chain, V lambda III.1, clone DPL23. The AC6C3 MAb lambda-chain employed a J segment with 98% homology to J3. The CR4E8 MAb light chain employed the J(H6-3C4) gene segment. Both MAbs utilized identical VH and JH gene segments and different DH segments. The VH regions of the AC6C3 MAb and of the CR4E8 MAb had, respectively, 98.6% and 98.98% homology to the human Ig germline heavy chain V region DP-7, a member of the VH-1 gene family.(ABSTRACT TRUNCATED AT 400 WORDS)</p>","PeriodicalId":77166,"journal":{"name":"Human antibodies and hybridomas","volume":"5 3-4","pages":"131-42"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human antibodies and hybridomas","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We have employed conventional polymerase chain reaction (PCR) and nonpalindromic adaptor PCR (NPA-PCR) for the amplification of the heavy- and light-chain transcripts of the cDNAs of two human monoclonal antibodies (MAb), designated AC6C3 (IgM, lambda) and CR4E8 (IgM, lambda), recognizing two different antigens expressed on the cell surface of human ovarian, cervix, breast, colon, melanoma and other carcinomas. With few exceptions these MAbs do not react with normal tissues. The AC6C3 MAb was developed by fusing regional lymph node lymphocytes from a patient with ovarian carcinoma with cells of the hybrid myeloma line SPAZ4, whereas the CR4E8 MAb was developed by fusing SPAZ4 cells with peripheral blood lymphocytes from a patient with cervical cancer, who was immunized intralymphatically with a viral oncolysate allogeneic tumor vaccine. The AC6C3 MAb immunoprecipitated from lysates of the ovarian tumor cell line SKOV3 a 32 kD polypeptide. The CR4E8 MAb reacted in Western blotting of lysates of the SW756 cervical carcinoma line with a 55 kD band. Cell surface immunofluorescence determinations using the fluorescence activated cell sorter revealed that both MAbs stain ovarian or cervix carcinoma tumor cell lines. We amplified the heavy chain transcripts of these two MAbs by conventional PCR, using mixed 5' end amplification primers, corresponding to the most conserved VH leader sequences and a C mu probe as a 3' end amplification primer. However, the mixed primer approach did not permit the amplification of the lambda-chain transcripts of these two human MAbs. This amplification was successfully carried out using the NPA-PCR that we have previously developed, specifically for the amplification of transcripts with unknown or variable 5' end, such as the T-cell receptors and the immunoglobulins. We have cloned and sequenced the amplified cDNAs. Sequence analysis showed that the V lambda segment of the AC6C3 MAb had 80.29% homology to the human germline Ig lambda-chain V lambda III.1, clone DPL2. The V lambda region of the CR4E8 MAb had 99.28% homology also to the human germline Ig lambda-chain, V lambda III.1, clone DPL23. The AC6C3 MAb lambda-chain employed a J segment with 98% homology to J3. The CR4E8 MAb light chain employed the J(H6-3C4) gene segment. Both MAbs utilized identical VH and JH gene segments and different DH segments. The VH regions of the AC6C3 MAb and of the CR4E8 MAb had, respectively, 98.6% and 98.98% homology to the human Ig germline heavy chain V region DP-7, a member of the VH-1 gene family.(ABSTRACT TRUNCATED AT 400 WORDS)

用非回文接头聚合酶链反应(NPA-PCR)扩增免疫球蛋白转录物。识别卵巢癌、宫颈癌、乳腺癌、结肠癌等肿瘤细胞表面抗原的两种人单克隆抗体的核苷酸序列分析。
我们采用传统的聚合酶链式反应(PCR)和非回文适应PCR (NPA-PCR)扩增了两种人单克隆抗体(MAb)的重链和轻链转录本,分别命名为AC6C3 (IgM, lambda)和CR4E8 (IgM, lambda),识别了在人卵巢癌、宫颈癌、乳腺癌、结肠癌、黑色素瘤和其他癌症细胞表面表达的两种不同抗原。除了少数例外,这些单克隆抗体不与正常组织发生反应。AC6C3单抗是通过将卵巢癌患者的局部淋巴结淋巴细胞与杂交骨髓瘤细胞系SPAZ4细胞融合而成的,而CR4E8单抗是通过将SPAZ4细胞与宫颈癌患者的外周血淋巴细胞融合而成的,该患者在淋巴细胞内接种了病毒溶瘤液异体肿瘤疫苗。从卵巢肿瘤细胞系skov3a 32kd多肽的裂解物中免疫沉淀AC6C3单抗。CR4E8单抗在SW756宫颈癌细胞系裂解物的Western blotting中反应,条带为55 kD。使用荧光活化细胞分选器对细胞表面进行免疫荧光检测,结果显示两种单克隆抗体均可染色卵巢癌或宫颈癌肿瘤细胞系。我们使用与最保守的VH引物序列对应的混合5′端扩增引物和一个C mu探针作为3′端扩增引物,通过常规PCR扩增了这两个单抗的重链转录本。然而,混合引物方法不允许扩增这两种人单克隆抗体的lambda链转录本。利用我们之前开发的NPA-PCR技术,我们成功地扩增了未知或可变5'端转录本,如t细胞受体和免疫球蛋白。我们对扩增的cdna进行了克隆和测序。序列分析显示,AC6C3单抗的V lambda片段与人种系Ig lambda链V lambda III.1克隆DPL2同源性为80.29%。CR4E8单抗的V lambda区与人种系Ig lambda链V lambda III.1克隆DPL23的同源性为99.28%。AC6C3单抗的lambda-chain包含一个J片段,与J3同源性为98%。CR4E8单抗轻链采用J(H6-3C4)基因片段。这两种单克隆抗体利用相同的VH和JH基因片段和不同的DH片段。AC6C3单抗和CR4E8单抗的VH区分别与人Ig种系重链V区DP-7 (VH-1基因家族成员)具有98.6%和98.98%的同源性。(摘要删节为400字)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信